Healthcare News | BioTuesdays by Kilmer Lucas IR

Markets

Analysts start Alpha Teknova at outperform, buy

Analysts for William Blair and BTIG initiated coverage of Alpha Teknova (NASDAQ:TKNO) with “outperform” and “buy” ratings, respectively, citing the company’s exposure to several large, rapidly growing markets. “In...

July 20, 2021

Markets

SVB Leerink starts Elevation Oncology at OP; PT $20

SVB Leerink launched coverage of Elevation Oncology (NASDAQ:ELEV) with an “outperform” rating and $20 price target. The stock closed at $12.10 on July 19. Elevation is a clinical development-stage biotech company...

July 20, 2021

Markets

WB starts Talkspace at outperform

William Blair launched coverage of Talkspace (NASDAQ:TALK) with an “outperform” rating, pointing to the company’s platform and significant market opportunity. The stock closed at $5.81 on July 16. “We believe the...

July 19, 2021

Markets

Maxim transfers coverage of Immutep at buy; PT $8

Maxim Group transferred primary coverage of Immutep (NASDAQ:IMMP) to analyst, Naureen Quibria, Ph.D., with a “buy” rating and $8 price target. The stock closed at $3.53 on July 15. Immutep has a pipeline of...

July 16, 2021

Developments

iBio posts positive preclinical immunization studies with next gen COVID-19 vaccine candidate

iBio (NYSE American:IBIO) announced that preclinical studies of IBIO-202, its subunit vaccine candidate that targets the nucleocapsid (N) protein of SARS-CoV-2, demonstrated a robust, antigen-specific, memory T-cell...

July 16, 2021

Developments

Cognetivity ICA test to be deployed in new NHS brain clinic in UK

Cognetivity Neurosciences’ (CSE:CGN; OTCQB:CGNSF) Integrated Cognitive Assessment (ICA) test is to form an integral part of a new and highly innovative clinic in the UK’s National Health Service (NHS) dedicated to...

July 15, 2021

Markets

Canaccord ups Acutus Medical to buy from hold; PT to $18 from $11

Canaccord Capital upgraded Acutus Medical (NASDAQ:AFIB) to “buy” from “hold” and raised its price target to $18 from $11, citing the company’s pre-announcement of second quarter results, which “illustrate early signs of...

July 15, 2021

Developments

TransMedics receives positive FDA AdCom vote for OCS Liver System

The FDA’s Gastroenterology and Urology Devices Panel, after a review and discussion, issued a favorable vote in support of approval of TransMedics Group’s (NASDAQ:TMDX) OCS Liver System. The panel voted 14-to-0...

July 15, 2021

Developments

ENA Respiratory begins Phase 1 study of COVID-19 preventative nasal spray

Closely-held ENA Respiratory of Australia initiated a Phase 1 human safety study of INNA-051, being developed to activate innate immunity in the nose, the primary entry portal of most respiratory viral infections. A...

July 14, 2021

Developments

Mesosil raises $675,000 seed round led by Archangel and NorthSpring Capital

Mesosil, a closely-held company developing the first lifetime-effect antimicrobial materials for dental and medical devices, closed an initial seed round of $675,000 led by the Archangel Network of Funds and NorthSpring...

July 13, 2021

Developments

Hepion posts positive Phase 2a NASH data in AMBITION trial

Hepion Pharmaceuticals (NASDAQ:HEPA) reported that all primary endpoints were met in its Phase 2a AMBITION clinical trial in patients with non-alcoholic steatohepatitis (NASH). The Phase 2a trial was designed to...

July 13, 2021

Developments

FDA approves expanded use for Pivot smoking cessation sensor

Carrot Inc., a closely-held digital health company, received expanded use indications for its Pivot Carbon Monoxide Breath Sensor in a new 510(k) clearance by the FDA based on published clinical trial data. As the only...

July 12, 2021

Analysts start Alpha Teknova at outperform, buy

SVB Leerink starts Elevation Oncology at OP; PT $20

WB starts Talkspace at outperform

Maxim transfers coverage of Immutep at buy; PT $8

iBio posts positive preclinical immunization studies with next gen COVID-19 vaccine candidate

Cognetivity ICA test to be deployed in new NHS brain clinic in UK

Canaccord ups Acutus Medical to buy from hold; PT to $18 from $11

TransMedics receives positive FDA AdCom vote for OCS Liver System

ENA Respiratory begins Phase 1 study of COVID-19 preventative nasal spray

Mesosil raises $675,000 seed round led by Archangel and NorthSpring Capital

Hepion posts positive Phase 2a NASH data in AMBITION trial

FDA approves expanded use for Pivot smoking cessation sensor

General

More